8-KItem 5.02 · Officer/Director ChangeItem 8.01 · Other EventsItem 9.01 · Financial Statements
Boston Scientific names Joseph Fitzgerald COO and reorganizes business segments
Filed with the SEC on · Summarized by InvestorsBot
Boston Scientific appointed Joseph M. Fitzgerald executive vice president and chief operating officer, effective January 1, 2027, overseeing global operations, business units and regions. The company will establish three reportable segments—Interventional Therapies, Rhythm Solutions and MedSurg—intended to speed decision-making and improve investment allocation; Interventional Therapies will include Penumbra following the anticipated acquisition close.